Annual Operating Profit
-$31.38 M
-$3.69 M-13.31%
December 31, 2023
Summary
- As of February 7, 2025, ATOS annual operating income is -$31.38 million, with the most recent change of -$3.69 million (-13.31%) on December 31, 2023.
- During the last 3 years, ATOS annual operating profit has fallen by -$16.77 million (-114.81%).
- ATOS annual operating profit is now -2810.67% below its all-time high of -$1.08 million, reached on December 31, 2010.
Performance
ATOS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$6.38 M
+$720.00 K+10.13%
September 30, 2024
Summary
- As of February 7, 2025, ATOS quarterly operating income is -$6.38 million, with the most recent change of +$720.00 thousand (+10.13%) on September 30, 2024.
- Over the past year, ATOS quarterly operating profit has increased by +$1.08 million (+14.50%).
- ATOS quarterly operating profit is now -6795.25% below its all-time high of -$92.60 thousand, reached on September 30, 2009.
Performance
ATOS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$29.49 M
+$1.08 M+3.54%
September 30, 2024
Summary
- As of February 7, 2025, ATOS TTM operating income is -$29.49 million, with the most recent change of +$1.08 million (+3.54%) on September 30, 2024.
- Over the past year, ATOS TTM operating profit has increased by +$1.01 million (+3.31%).
- ATOS TTM operating profit is now -31745.57% below its all-time high of -$92.60 thousand, reached on September 30, 2009.
Performance
ATOS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ATOS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.3% | +14.5% | +3.3% |
| 3 y3 years | -114.8% | -23.8% | -48.0% |
| 5 y5 years | -174.4% | -23.8% | -48.0% |
ATOS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.9% | at low | -34.5% | +29.2% | -43.7% | +6.0% |
| 5 y | 5-year | -114.8% | at low | -144.0% | +29.2% | -130.6% | +6.0% |
| alltime | all time | -2810.7% | at low | -6795.3% | +29.2% | <-9999.0% | +6.0% |
Atossa Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.38 M(-10.1%) | -$29.49 M(-3.5%) |
| Jun 2024 | - | -$7.11 M(+1.8%) | -$30.57 M(-2.2%) |
| Mar 2024 | - | -$6.98 M(-22.6%) | -$31.26 M(-0.4%) |
| Dec 2023 | -$31.38 M(+13.3%) | -$9.02 M(+20.8%) | -$31.38 M(+2.9%) |
| Sep 2023 | - | -$7.47 M(-4.2%) | -$30.50 M(-2.4%) |
| Jun 2023 | - | -$7.79 M(+9.8%) | -$31.23 M(+4.0%) |
| Mar 2023 | - | -$7.10 M(-12.8%) | -$30.04 M(+8.5%) |
| Dec 2022 | -$27.69 M(+34.9%) | -$8.14 M(-0.8%) | -$27.68 M(+13.6%) |
| Sep 2022 | - | -$8.21 M(+24.4%) | -$24.38 M(+14.3%) |
| Jun 2022 | - | -$6.59 M(+38.9%) | -$21.33 M(-1.9%) |
| Mar 2022 | - | -$4.75 M(-1.7%) | -$21.74 M(+5.9%) |
| Dec 2021 | -$20.52 M(+40.5%) | -$4.83 M(-6.4%) | -$20.52 M(+3.0%) |
| Sep 2021 | - | -$5.16 M(-26.4%) | -$19.92 M(+9.0%) |
| Jun 2021 | - | -$7.00 M(+98.4%) | -$18.27 M(+20.2%) |
| Mar 2021 | - | -$3.53 M(-16.4%) | -$15.20 M(+4.1%) |
| Dec 2020 | -$14.61 M(-15.4%) | -$4.23 M(+20.4%) | -$14.61 M(+12.4%) |
| Sep 2020 | - | -$3.51 M(-10.8%) | -$13.00 M(+1.6%) |
| Jun 2020 | - | -$3.94 M(+34.0%) | -$12.79 M(-20.8%) |
| Mar 2020 | - | -$2.94 M(+12.2%) | -$16.14 M(-6.5%) |
| Dec 2019 | -$17.27 M(+51.0%) | -$2.62 M(-20.7%) | -$17.27 M(+3.0%) |
| Sep 2019 | - | -$3.30 M(-54.7%) | -$16.76 M(-0.1%) |
| Jun 2019 | - | -$7.29 M(+79.3%) | -$16.77 M(+23.1%) |
| Mar 2019 | - | -$4.06 M(+92.9%) | -$13.62 M(+19.2%) |
| Dec 2018 | -$11.43 M(+59.1%) | -$2.11 M(-36.3%) | -$11.43 M(+5.3%) |
| Sep 2018 | - | -$3.31 M(-20.1%) | -$10.86 M(+13.1%) |
| Jun 2018 | - | -$4.14 M(+121.0%) | -$9.60 M(+30.5%) |
| Mar 2018 | - | -$1.87 M(+22.4%) | -$7.36 M(+2.4%) |
| Dec 2017 | -$7.19 M | -$1.53 M(-25.5%) | -$7.19 M(-3.7%) |
| Sep 2017 | - | -$2.06 M(+8.4%) | -$7.46 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | -$1.90 M(+11.3%) | -$6.96 M(+2.6%) |
| Mar 2017 | - | -$1.70 M(-5.6%) | -$6.79 M(-8.4%) |
| Dec 2016 | -$7.25 M(-43.2%) | -$1.80 M(+15.8%) | -$7.41 M(-8.3%) |
| Sep 2016 | - | -$1.56 M(-9.5%) | -$8.08 M(-22.0%) |
| Jun 2016 | - | -$1.72 M(-26.0%) | -$10.37 M(-12.3%) |
| Mar 2016 | - | -$2.33 M(-5.9%) | -$11.81 M(-7.4%) |
| Dec 2015 | -$12.76 M(+29.9%) | -$2.47 M(-35.6%) | -$12.76 M(+13.3%) |
| Sep 2015 | - | -$3.84 M(+21.2%) | -$11.26 M(+5.6%) |
| Jun 2015 | - | -$3.17 M(-3.1%) | -$10.66 M(-0.1%) |
| Mar 2015 | - | -$3.27 M(+235.4%) | -$10.68 M(+8.8%) |
| Dec 2014 | -$9.82 M(-9.0%) | -$975.70 K(-69.9%) | -$9.82 M(-15.4%) |
| Sep 2014 | - | -$3.25 M(+1.8%) | -$11.60 M(-2.2%) |
| Jun 2014 | - | -$3.19 M(+32.2%) | -$11.86 M(+5.4%) |
| Mar 2014 | - | -$2.41 M(-12.6%) | -$11.25 M(+4.4%) |
| Dec 2013 | -$10.78 M(+112.8%) | -$2.76 M(-21.2%) | -$10.78 M(+10.8%) |
| Sep 2013 | - | -$3.50 M(+35.6%) | -$9.73 M(+32.1%) |
| Jun 2013 | - | -$2.58 M(+33.1%) | -$7.37 M(+23.8%) |
| Mar 2013 | - | -$1.94 M(+13.8%) | -$5.95 M(+17.3%) |
| Dec 2012 | -$5.07 M(+47.8%) | -$1.71 M(+50.2%) | -$5.07 M(+11.1%) |
| Sep 2012 | - | -$1.14 M(-2.6%) | -$4.56 M(-2.9%) |
| Jun 2012 | - | -$1.17 M(+9.8%) | -$4.70 M(+9.5%) |
| Mar 2012 | - | -$1.06 M(-11.3%) | -$4.29 M(+24.2%) |
| Dec 2011 | -$3.43 M(+218.1%) | -$1.20 M(-6.0%) | -$3.45 M(+33.1%) |
| Sep 2011 | - | -$1.27 M(+68.3%) | -$2.59 M(+44.3%) |
| Jun 2011 | - | -$756.90 K(+235.8%) | -$1.80 M(+45.2%) |
| Mar 2011 | - | -$225.40 K(-33.4%) | -$1.24 M(+22.3%) |
| Dec 2010 | -$1.08 M | -$338.40 K(-29.1%) | -$1.01 M(+50.2%) |
| Sep 2010 | - | -$477.30 K(+142.0%) | -$674.50 K(+132.7%) |
| Jun 2010 | - | -$197.20 K(+113.0%) | -$289.80 K(+213.0%) |
| Sep 2009 | - | -$92.60 K | -$92.60 K |
FAQ
- What is Atossa Therapeutics annual operating income?
- What is the all time high annual operating profit for Atossa Therapeutics?
- What is Atossa Therapeutics annual operating profit year-on-year change?
- What is Atossa Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Atossa Therapeutics?
- What is Atossa Therapeutics quarterly operating profit year-on-year change?
- What is Atossa Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Atossa Therapeutics?
- What is Atossa Therapeutics TTM operating profit year-on-year change?
What is Atossa Therapeutics annual operating income?
The current annual operating profit of ATOS is -$31.38 M
What is the all time high annual operating profit for Atossa Therapeutics?
Atossa Therapeutics all-time high annual operating income is -$1.08 M
What is Atossa Therapeutics annual operating profit year-on-year change?
Over the past year, ATOS annual operating income has changed by -$3.69 M (-13.31%)
What is Atossa Therapeutics quarterly operating income?
The current quarterly operating profit of ATOS is -$6.38 M
What is the all time high quarterly operating profit for Atossa Therapeutics?
Atossa Therapeutics all-time high quarterly operating income is -$92.60 K
What is Atossa Therapeutics quarterly operating profit year-on-year change?
Over the past year, ATOS quarterly operating income has changed by +$1.08 M (+14.50%)
What is Atossa Therapeutics TTM operating income?
The current TTM operating profit of ATOS is -$29.49 M
What is the all time high TTM operating profit for Atossa Therapeutics?
Atossa Therapeutics all-time high TTM operating income is -$92.60 K
What is Atossa Therapeutics TTM operating profit year-on-year change?
Over the past year, ATOS TTM operating income has changed by +$1.01 M (+3.31%)